Supplementary Figure 4 from Endoglin-Directed CAR T Cells Comprehensively Target Tumors in Advanced Sarcomas

Q: What type of study is this?

This is a Experimental Study study.

H Berger; Malina Maharana; Jorge Rivera Mirabal; Lyazat Kurenbekova; Alberto Delaidelli; Atreyi Dasgupta; Ahmed Z. Gad; Mohamed F. Sheha; Sybrina S. Kerr; Ada I. Ozcan; Jessica S. Morris; Angela M. Major; John Hicks; Mary K. McKenna; Ben K. Seon; Matthew L. Baker; Poul H. Sorensen; Meenakshi Hegde; Jason T. Yustein; Nabil Ahmed; Sujith K. Joseph

doi:10.1158/2326-6066.30255005

Key Points

CAR T cells effectively target tumors in advanced sarcomas, enhancing treatment options.
Binding of recombinant endoglin to CAR T cells improves targeting of sarcoma tumors.
Experimental analysis assessed the impact of CAR T cells on tumor targeting and effectiveness.
Findings suggest that targeting endoglin may enhance immunotherapy strategies in treating sarcomas.

No abstract yet

We only have this paper's title and publication details.

Read it at the source

Implication

Experimental evidence shows that CAR T cells directed at endoglin effectively target tumors in sarcomas, indicating a potential immunotherapy approach.

Abstract

Binding of recombinant ENG to CAR-T.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Berger et al. (2025) studied this question.

synapsesocial.com/papers/68de68f183cbc991d0a21adb https://doi.org/10.1158/2326-6066.30255005

View at Publisher

Ask AI

Bookmark

Share

Supplementary Figure 4 from Endoglin-Directed CAR T Cells Comprehensively Target Tumors in Advanced Sarcomas

Key Points

No abstract yet

Implication

Abstract

Discussion

Cite This Study

Supplementary Figure 4 from Endoglin-Directed CAR T Cells Comprehensively Target Tumors in Advanced Sarcomas

Key Points

No abstract yet

Implication

Abstract

Discussion

Cite This Study

Keep reading

More related papers

Keep reading

More related papers